Teleflex (TFX) Receives FDA 510(k) Clearance for its Arrow® VPS Rhythm™ Device with Optional TipTracker™ Technology
510(k) Clearance for the Arrow® VPS Rhythm™ Device expands Teleflex’s Catheter Tip Navigation and Placement portfolio to now include familiar ECG-only technology for the elimination of chest X-ray
The Arrow® VPS Rhythm™ Device is a simple and versatile solution that provides ECG-based tip confirmation in a highly portable and lightweight design.
The Arrow® VPS Rhythm™ Device assists in placement and confirmation of a catheter tip in the SVC-CAJ (superior vena-cava-cavoatrial junction); it may be used with a broad range of catheter types and brands. Intravascular P-wave changes are saved as the catheter approaches the SVC, helping to identify the lower 1/3 of the SVC, near the CAJ, eliminating the need for confirmatory chest X-ray or fluoroscopy in adult patients. When paired with the single-use TipTracker™ Stylet for insertion of peripherally-inserted central catheters (PICCs), the Arrow® VPS Rhythm™ Device provides real-time visual navigation by tracing the catheter pathway with a blue line on a color screen. The Device has an expansive sphere of visual navigation to provide easy navigation of the PICC during insertion.
“This clearance positions us to provide catheter tip placement solutions
that meet customer’s unique therapeutic and budgetary needs,” said
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
Treasurer and Vice President, Investor Relations